(Pre)diabetes, glycemia, and daily glucose variability are associated with retinal nerve fiber layer thickness in The Maastricht Study

Autor: Frank C. T. van der Heide, Yuri D. Foreman, Iris W. M. Franken, Ronald M. A. Henry, Abraham A. Kroon, Pieter C. Dagnelie, Simone J. P. M. Eussen, Tos T. J. M. Berendschot, Jan S. A. G. Schouten, Carroll A. B. Webers, Miranda T. Schram, Carla J. H. van der Kallen, Marleen M. J. van Greevenbroek, Anke Wesselius, Casper G. Schalkwijk, Nicolaas C. Schaper, Martijn C. G. J. Brouwers, Coen D. A. Stehouwer

Publikováno v: Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)

Abstract Retinopathy and neuropathy in type 2 diabetes are preceded by retinal nerve fibre layer (RNFL) thinning, an index of neurodegeneration. We investigated whether glucose metabolism status (GMS), measures of glycaemia, and daily glucose variabi

Externí odkaz: https://doaj.org/article/136796e650d14f86ba6dabb1b934711c

Fatigue in adults with Osteogenesis Imperfecta

Autor: Arjan G. J. Harsevoort, Koert Gooijer, Fleur S. van Dijk, Daniëlle A. F. M. van der Grijn, Anton A. M. Franken, Anne Marieke V. Dommisse, Guus J. M. Janus

Publikováno v: BMC Musculoskeletal Disorders, Vol 21, Iss 1, Pp 1-6 (2020)

Abstract Background Osteogenesis Imperfecta (OI) is characterized by bone fragility, and features such as blue sclerae, dentinogenesis imperfecta, hearing loss, ligamentous laxity and short stature can be present. It has long been assumed that the fu

Externí odkaz: https://doaj.org/article/e26416ad40c24bc0a9be1729b18161d3

Prevalence of scoliosis and impaired pulmonary function in patients with type III osteogenesis imperfecta

Autor: M. C. Keuning, S. J. G. Leeuwerke, P. R. van Dijk, A. G. J. Harsevoort, H. P. Grotjohan, A. A. M. Franken, G. J. M. Janus

Publikováno v: European Spine Journal, 31. SPRINGER

Purpose Osteogenesis Imperfecta (OI) is a rare group of congenital genetic disorders that consists of a collagen synthesis defect. The most severe phenotype is type III OI. Characterized by progressive bone deformity, fragility and pulmonary impairme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5054f65a2ec27b9a5a7b605631767c5
https://doi.org/10.1007/s00586-022-07260-5

What is the added value of patch testing with 30 fragrance allergens in addition to the European Baseline series?

Autor: Rosalie C. Krijl, Norbertus A. Ipenburg, Sylvie M. Franken, Thomas Rustemeyer

Publikováno v: Krijl, R C, Ipenburg, N A, Franken, S M & Rustemeyer, T 2022, ' What is the added value of patch testing with 30 fragrance allergens in addition to the European Baseline series? ', Contact Dermatitis, vol. 86, no. 5, pp. 390-397 . https://doi.org/10.1111/cod.14065
Contact dermatitis, 86(5), 390-397. Wiley-Blackwell
Contact Dermatitis, 86(5), 390-397. Wiley-Blackwell

Background: Patch testing with the fragrance allergy markers in the European baseline series (EBS) does not identify all patients with fragrance allergy. Hydroperoxides of linalool and limonene have been shown to be useful allergens in detecting frag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb4761e9e077dbaca65879edc9c98cf
https://research.vumc.nl/en/publications/6237077c-1883-42bc-adbe-b3bb58852f57

Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs

Autor: Gap Hospers, M Franken, A.C.J. van Akkooi, H.M. Westgeest, Ellen Kapiteijn, Marye J Boers-Sonderen, R van Rijn, Mieke J. Aarts, A.J.M. van den Eertwegh, F van den Berkmortel, J.W.B. de Groot, Michel W.J.M. Wouters, B Leeneman, C.A. Uyl-de Groot, Karijn P M Suijkerbuijk, J.B.A.G. Haanen, A.A.M. Van der Veldt, Djura Piersma

Publikováno v: ESMO Open, 6(6):100320. BMJ PUBLISHING GROUP
ESMO Open, 6(6):100320. BMJ Publishing Group
Esmo Open, 6, 6
Franken, M G, Leeneman, B, Aarts, M J B, van Akkooi, A C J, van den Berkmortel, F W P J, Boers-Sonderen, M J, van den Eertwegh, A J M, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, van der Veldt, A A M, Westgeest, H M, Wouters, M W J M, Haanen, J B A G & Uyl-de Groot, C A 2021, ' Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs ', ESMO OPEN, vol. 6, no. 6, 100320 . https://doi.org/10.1016/j.esmoop.2021.100320
ESMO OPEN, 6(6):100320. BMJ Publishing Group
Esmo Open, 6
ESMO Open

Background The objective of this study was to evaluate trends in survival and health care costs in metastatic melanoma in the era of targeted and immunotherapeutic drugs. Materials and methods Data on survival and health care resource use were retrie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea39d269770e5d944e6d16f2b5d3805c
https://research.rug.nl/en/publications/7a2faa86-1f60-41de-bb5a-6d3d09d52114